Search clinical trials for: Sodium lauryl sulfate (Sigma Aldrich) 1.0%

Total 45 results

Kimberly-Clark Corporation

Completed

A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants

Dermatitis

United States
Yonsei University

Completed

Effect of Sodium Lauryl Sulfate on Recurrent Aphthous Stomatitis

Recurrent Aphthous Stomatitis
Pfizer

Completed

Cumulative Irritation Test

Tinea Pedis

United States
Maruho North America Inc.

Completed

Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers

Healthy Volunteers

United States
Laval University

Completed

Spermicidal Efficacy Of A Vaginal Gel

Contraception

Canada
Pyramid Biosciences

Completed

A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants

Healthy Volunteers

United States
Maruho North America Inc.

Completed

Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers

Healthy Volunteers

United States
Dr. Reddy's Laboratories Limited
TKL Research, Inc.; Accelovance

Completed

Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion

Head Lice

United States
Pfizer

Completed

A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804

Healthy

Singapore
Dr. Reddy's Laboratories Limited

Completed

Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion

Head Lice

United States
Pfizer

Completed

RIPT of Ibuprofen Topical Gel

Pain

United States
University of California, San Francisco
Food and Drug Administration (FDA)

Recruiting

Excipient Effect on Drug Absorption in Humans

The Impact of Excipients on Drug Absorption

United States
Pfizer

Completed

Cumulative Irritation Test

Onychomycosis

United States
University of Split, School of Medicine

Completed

Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery

Irritant Contact Dermatitis

Croatia
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Acne Vulgaris

United States
LEO Pharma
Bayer

Completed

21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation

Healthy

United States
Pulmatrix Inc.

Completed

21 Day Cumulative Skin Irritation of RUT058-60

Irritation/Irritant

United States
Biosplice Therapeutics, Inc.

Completed

A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers

Tendinopathy

United States
Goldman, Butterwick, Fitzpatrick and Groff

Not yet recruiting

Treatment of Epidermoid Cysts

Epidermoid Cyst
Bayer

Completed

Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

Hypersensitivity

United States
Medline Industries

Completed

Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth

Surgery

United States
Almirall, S.A.
Allergan

Completed

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Healthy Volunteers

United States
Noah Rosenberg, MD

Completed

Neo-Synalar Modified 48 Hour Patch Test

Allergy

United States
Pfizer

Completed

Ibuprofen 5% Topical Gel CIPT

Pain

United States
Zurex Pharma, Inc.

Completed

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Surgical Site Infection

United States
Ventrus Biosciences, Inc

Unknown

Topical Safety Study of Topical Diltiazem Hydrochloride

Diltiazem Skin Sensitivity.

United States
GlaxoSmithKline

Completed

A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel

Pain

United States
Ventrus Biosciences, Inc

Unknown

A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design

Skin Irritation

United States
University of Beykent

Completed

Investigation of the Relationship Between Taste Perception and Caries Activity in School Children

Healthy
DSM Nutritional Products, Inc.

Completed

Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol

Sunburn

United States
NovoBliss Research Pvt Ltd
Nanobrid Innovations Private Limited

Not yet recruiting

Primary Irritation Patch Test (PIPT) Study Conducted at NovoBliss Research for Shared Panel

Healthy
National Cancer Institute, Egypt

Completed

Magnesium Versus High Dose Fentanyl in Endotracheal Intubation

Stress Response

Egypt
Avanir Pharmaceuticals
Syneos Health

Completed

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (STAR)

Pseudobulbar Affect (PBA)

United States, Argentina, Brazil
Assiut University

Completed

Postoperative Epidural Analgesia in Spine Fusion Surgery

Pain

Egypt
Baskent University

Completed

Intrathecal Levobupivacaine With Opioids for Caesarean Section

Elective Caesarean Section Surgeries

Turkey
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma | Stage 1 Neuroblastoma | Stage 2 Neuroblastoma

United States, Canada, Australia, New Zealand
National Cancer Institute (NCI)

Recruiting

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

United States, Puerto Rico, Israel
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Adult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditions

United States, Canada, Australia, New Zealand
National Cancer Institute (NCI)

Active, not recruiting

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

B Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

United States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Choriocarcinoma | Embryonal Carcinoma | Mixed Germ Cell Tumor | Central Nervous System Nongerminomatous Germ Cell Tumor | Immature Teratoma | Malignant Teratoma | Pineal Region Germ Cell Tumor | Pineal Region Immature Teratoma | Pineal Region Yolk Sac Tumor | Suprasellar Germ Cell Tumor

United States, Australia, Canada, New Zealand
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Acute Lymphoblastic Leukemia in Remission

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic Leukemia

United States, Canada, Australia
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany
M.D. Anderson Cancer Center

Recruiting

Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Recurrent Adult Lymphoblastic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia | Refractory Lymphoblastic Lymphoma

United States

Search clinical trials for: Sodium lauryl sulfate (Sigma Aldrich) 1.0%

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations